This does not mean LifeVantage is worthless
But he said there is potential for long-term savings if people can use these medications to better manage or prevent risks and complications related to obesity, including heart disease, diabetes, cancer, kidney disease, osteoarthritis, asthma and more
In a 48-week phase 2 trial published in The New England Journal of Medicine , adults with obesity (without type 2 diabetes) receiving once-weekly subcutaneous retatrutide at the 12 mg amount achieved a least-squares mean body weight reduction of 24.2%, compared with 2.1% in the placebo group [1]
For some people, the right answer may be patience rather than urgency
These side effects can be frustrating, but they dont have to derail your health journey